Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with F
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q1 2024 | FD&C YELLOW NO. 6 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | 2mg | Correction | ||
| Q2 2024 | FD&C YELLOW NO. 6 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | 0.39 mg | Correction | ||
| Q2 2024 | FERROSOFERRIC OXIDE | ORAL | CAPSULE, LIQUID FILLED | NA | Deletion | ||
| Q1 2024 | FD&C YELLOW NO. 6 | ORAL | CAPSULE, LIQUID FILLED | 0.18 mg | MDE Replacement | ||
| Q2 2024 | FD&C YELLOW NO. 6 | ORAL | CAPSULE, LIQUID FILLED | 1mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: March 15, 2024
Database Last Updated: April 29, 2024